Advanced search
Publication Cover
Cell Cycle Volume 16, 2017 - Issue 8
Submit an article Journal homepage
1,564
Views
7
CrossRef citations to date
0
Altmetric
Editorials: Cell Cycle Features

DNA damage players are linked to HIF-1α/hypoxia signaling

Abdol-Hossein RezaeianDepartment of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
,
Yu-Hui WangDepartment of Cancer Biology, Wake Forest University School of Medicine Medical Center Blvd, Winston-Salem, NC, USA
&
Hui-Kuan LinDepartment of Cancer Biology, Wake Forest University School of Medicine Medical Center Blvd, Winston-Salem, NC, USA;Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan;Department of Biotechnology, Asia University, Taichung, TaiwanCorrespondence[email protected]
Pages 725-726 | Received 08 Feb 2017, Accepted 15 Feb 2017, Published online: 24 Mar 2017

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Evan R. Zynda, Mitchell H. Maloy & Eugene S. Kandel. (2019) The role of PAK1 in the sensitivity of kidney epithelial cells to ischemia-like conditions. Cell Cycle 18:5, pages 596-604.
Read now
Yu Xia, Lixia Jiang & Tianyu Zhong. (2018) The role of HIF-1α in chemo-/radioresistant tumors. OncoTargets and Therapy 11, pages 3003-3011.
Read now

Articles from other publishers (5)

Hamid A. Bakshi, Michella Mkhael, Hakkim L. Faruck, Asad Ullah Khan, Alaa A.A. Aljabali, Vijay Mishra, Mohamed El-Tanani, Nitin B. Charbe & Murtaza M. Tambuwala. (2024) Cellular signaling in the hypoxic cancer microenvironment: Implications for drug resistance and therapeutic targeting. Cellular Signalling 113, pages 110911.
Crossref
Ting-Wan Kao, Geng-Hao Bai, Tian-Li Wang, Ie-Ming Shih, Chi-Mu Chuang, Chun-Liang Lo, Meng-Chen Tsai, Li-Yun Chiu, Chu-Chien Lin & Yao-An Shen. (2023) Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistance. Journal of Experimental & Clinical Cancer Research 42:1.
Crossref
Bich Phuong Bui, Phuong Linh Nguyen, Kyeong Lee & Jungsook Cho. (2022) Hypoxia-Inducible Factor-1: A Novel Therapeutic Target for the Management of Cancer, Drug Resistance, and Cancer-Related Pain. Cancers 14:24, pages 6054.
Crossref
Mateusz Kciuk, Adrianna Gielecińska, Damian Kołat, Żaneta Kałuzińska & Renata Kontek. (2022) Cancer-associated transcription factors in DNA damage response. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:4, pages 188757.
Crossref
Hiroyuki Inuzuka, Jing Liu, Wenyi Wei & Abdol-Hossein Rezaeian. (2022) PROTAC technology for the treatment of Alzheimer’s disease: advances and perspectives. Acta Materia Medica 1:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.